ZA966969B - Medicaments - Google Patents

Medicaments

Info

Publication number
ZA966969B
ZA966969B ZA966969A ZA966969A ZA966969B ZA 966969 B ZA966969 B ZA 966969B ZA 966969 A ZA966969 A ZA 966969A ZA 966969 A ZA966969 A ZA 966969A ZA 966969 B ZA966969 B ZA 966969B
Authority
ZA
South Africa
Prior art keywords
medicaments
Prior art date
Application number
ZA966969A
Inventor
Hugh Brownlie Mcdade
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA966969B publication Critical patent/ZA966969B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
ZA966969A 1995-08-19 1996-08-16 Medicaments ZA966969B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9517022.1A GB9517022D0 (en) 1995-08-19 1995-08-19 Medicaments

Publications (1)

Publication Number Publication Date
ZA966969B true ZA966969B (en) 1997-03-24

Family

ID=10779487

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA966969A ZA966969B (en) 1995-08-19 1996-08-16 Medicaments

Country Status (6)

Country Link
EP (1) EP0844878A1 (en)
JP (1) JPH11512083A (en)
AU (1) AU6924796A (en)
GB (1) GB9517022D0 (en)
WO (1) WO1997006804A1 (en)
ZA (1) ZA966969B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9605293D0 (en) * 1996-03-13 1996-05-15 Glaxo Group Ltd Medicaments
US6767991B1 (en) 1997-08-11 2004-07-27 Boehringer Ingelheim (Canada) Ltd. Hepatitis C inhibitor peptides
EP1012180B1 (en) * 1997-08-11 2004-12-01 Boehringer Ingelheim (Canada) Ltd. Hepatitis c inhibitor peptide analogues
DE69933860T2 (en) * 1998-02-25 2007-05-31 Emory University 2'-FLUORONUKLEOSIDE
US6323180B1 (en) 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
US6608027B1 (en) 1999-04-06 2003-08-19 Boehringer Ingelheim (Canada) Ltd Macrocyclic peptides active against the hepatitis C virus
GB9909154D0 (en) * 1999-04-22 1999-06-16 Nippon Glaxo Limited Pharmaceutical formulation
WO2001007027A2 (en) * 1999-07-22 2001-02-01 Vertex Pharmaceuticals Incorporated Pyrimidine derivatives for the treatment of viral diseases
US7244721B2 (en) 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
HUP0303358A3 (en) 2000-07-21 2005-10-28 Schering Corp Novel peptides as ns3-serine protease inhibitors of hepatitis c virus and pharmaceutical compositions containing them
KR100939155B1 (en) 2000-07-21 2010-01-28 쉐링 코포레이션 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
CA2426187C (en) * 2000-10-18 2011-08-16 Pharmasset Limited Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
ES2350201T3 (en) 2002-05-20 2011-01-20 Bristol-Myers Squibb Company HETEROCYCLIC SULPHAMIDES AS INHIBITORS OF HEPATITIS C VIRUS.
ES2361011T3 (en) 2002-05-20 2011-06-13 Bristol-Myers Squibb Company HEPATITIS VIRUS INHIBITORS C.
MY140680A (en) 2002-05-20 2010-01-15 Bristol Myers Squibb Co Hepatitis c virus inhibitors
EP1505945B1 (en) 2002-05-20 2008-11-05 Bristol-Myers Squibb Company Substituted cycloalkyl p1' hepatitis c virus inhibitors
DE602004010137T2 (en) 2003-05-21 2008-09-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg COMPOUNDS AS HEPATITIS C INHIBITORS
US20050058044A1 (en) * 2003-09-12 2005-03-17 Koegler John M. Optical disk modified for speed and orientation tracking
PE20050431A1 (en) 2003-09-22 2005-07-19 Boehringer Ingelheim Int MACROCYCLIC PEPTIDES ACTIVE AGAINST HEPATITIS C VIRUS
MXPA06003963A (en) 2003-10-14 2006-08-25 Intermune Inc Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication.
US7132504B2 (en) 2003-11-12 2006-11-07 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7135462B2 (en) 2003-11-20 2006-11-14 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7309708B2 (en) 2003-11-20 2007-12-18 Birstol-Myers Squibb Company Hepatitis C virus inhibitors
ES2358333T3 (en) 2004-01-21 2011-05-09 Boehringer Ingelheim International Gmbh MACROCYCLIC PEPTIDES WITH ACTION AGAINST THE VIRUS OF HEPATITIS C.
UY29016A1 (en) 2004-07-20 2006-02-24 Boehringer Ingelheim Int ANALOGS OF INHIBITING DIPEPTIDES OF HEPATITIS C
CA2573346C (en) 2004-07-20 2011-09-20 Boehringer Ingelheim International Gmbh Hepatitis c inhibitor peptide analogs
MX2008001166A (en) 2005-07-25 2008-03-18 Intermune Inc Novel macrocyclic inhibitors of hepatitis c virus replication.
ES2356776T3 (en) 2005-10-11 2011-04-13 Intermune, Inc. COMPOUNDS AND METHODS TO INHIBIT THE REPLICATION OF THE HEPATITIS VIRUS.
EP1968595A4 (en) * 2005-12-02 2014-05-21 Univ Yale Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs
UA98494C2 (en) 2007-06-29 2012-05-25 Гіліад Сайєнсіз, Інк. Antiviral compounds
BRPI0813733A2 (en) 2007-06-29 2019-11-05 Gilead Sciences Inc compound with hcv inhibitory activity, its pharmaceutical composition and its use.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives

Also Published As

Publication number Publication date
JPH11512083A (en) 1999-10-19
WO1997006804A1 (en) 1997-02-27
EP0844878A1 (en) 1998-06-03
AU6924796A (en) 1997-03-12
GB9517022D0 (en) 1995-10-25

Similar Documents

Publication Publication Date Title
HUP9801151A3 (en) Long-shelf-life medicaments
GB9517022D0 (en) Medicaments
GB9419536D0 (en) Medicaments
GB9406573D0 (en) Medicaments
GB9420784D0 (en) Medicaments
GB9526392D0 (en) Medicaments
GB9503850D0 (en) Medicaments
GB9418530D0 (en) Medicaments
GB9411052D0 (en) Medicaments
GB9421133D0 (en) Medicaments
GB9416365D0 (en) Medicaments
GB9515628D0 (en) Medicaments
GB9517021D0 (en) Medicaments
GB9524173D0 (en) Medicaments
GB9523453D0 (en) Medicaments
GB9521208D0 (en) Medicaments
GB9519585D0 (en) Medicaments
GB9519029D0 (en) Medicaments
GB9514723D0 (en) Medicaments
GB9519021D0 (en) Medicaments
GB9504153D0 (en) Medicaments
IL127776A0 (en) Medicaments
GB9506122D0 (en) Medicaments
GB9424013D0 (en) Medicaments
EP0790829A4 (en) Medicaments